An Ottawa life sciences firm has the green light to test the product in the world’s most populous country as it looks to reverse years of sustained losses.
Life sciences firm produces supplements aimed at replacing antibiotics in cattle feed.
Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve a market breakthrough.
An Ottawa-based firm that has landed millions of dollars in funding to develop an alternative to antibiotic-based livestock feed has begun trading on a U.S. stock exchange
An Ottawa-based company is refilling its trough of funding as it develops an alternative to antibiotic-based livestock feed
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to antibiotic-based livestock feed
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round it says will
Avivagen CEO Cameron Groome was sounding an upbeat tone Friday morning after his company announced it had secured $3.6 million in new funding in a private placement.